PerkinElmer Sues Intema over Down Syndrome Test IP | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer last week filed a suit against UK-based Intema seeking to invalidate that firm's US patent covering a Down syndrome test.

The suit, which was filed in the US District Court for the District of Massachusetts, seeks a declaration from the court that one or more of the claims of US Patent No. 6,573,103 are invalid. The patent is entitled, "Antenatal Screening for Down's Syndrome," and was issued in June 2003.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.